Chronos Archive seal
The Human Record

Eva Perón

Case HR-ML025 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
May 7, 1919 – July 26, 1952
Synthetic DOB
1994-05-07
Index visit
2026-02-09 at age 31
Synthetic MRN
HR-ML025-SYN

Teaching objective: Primary care and gynecologic oncology for a 31-year-old Spanish-speaking woman who has never had cervical screening and presents with abnormal bleeding and anemia: a speculum examination, direct biopsy of a visible cervical lesion with HPV testing and cytology, truthful and culturally sensitive disclosure of the diagnosis to the patient herself first, in her own language, with her choosing who else is told (the teaching contrast with the concealment of her historical diagnosis), FIGO 2018 staging with pelvic MRI and PET-CT, definitive chemoradiation with weekly cisplatin and image-guided brachytherapy for stage IIB disease, fertility and ovarian function counseling before treatment, management of anemia, treatment side effects and radiation-induced menopause, psychosocial support, and survivorship care, on the NCCN cervical cancer guideline, the FIGO 2018 staging system, the ASCCP 2019 management guidelines, the ASCO guidelines on patient-clinician communication, fertility preservation, and anxiety and depression, and the CMID anemia monograph.

Historical timeline

DateEventClaims
May 7, 1919Born in Los Toldos, Province of Buenos Aires.CLM-0001
October 22, 1945Married Juan Perón.CLM-0002
January 1950Fainted; appendectomy. Weakness and anemia from vaginal bleeding followed.CLM-0003
August 1951Advanced cervical cancer found; treated with radium.CLM-0004
November 1951Hysterectomy for cancer that had spread to adjacent pelvic organs; she was not told the diagnosis.CLM-0005
February 1952Recurrence confirmed without telling her; more radiotherapy, later chemotherapy.CLM-0006
1952Reported prefrontal lobotomy in the last months of her illness (contested reconstruction).CLM-0008
July 26, 1952Died, at 33.CLM-0007
June 3, 2000Barron Lerner's account of her illness published in The Lancet.CLM-0009

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D She was born Eva María Ibarguren on May 7, 1919, in Los Toldos, a village in the Province of Buenos Aires, Argentina; her marriage contract later gave her birth date as May 7, 1922. confirmed Goodwin PB Jr. Perón, Eva (1919-1952). Women in World History: A Biographical Encyclopedia supports
D She married Juan Perón on October 22, 1945, and became Argentina's first lady after his election in 1946. Her work for the poor made her a powerful political figure, and she is best known as Evita.
Identity only; her public work anchors the modern social history.
confirmed Goodwin PB Jr. Perón, Eva (1919-1952). Women in World History: A Biographical Encyclopedia supports
Altman LK. Eva Peron and her doctors' deceit supports
Nijensohn DE. Prefrontal lobotomy on Evita was done for behavior/personality modification, not just for pain control. Neurosurg Focus. 2015;39(1):E12 (PMID 26126398) supports
D Her medical ordeal began in January 1950, when she was 30: she fainted and underwent an appendectomy. Despite persistent weakness and anemia from vaginal bleeding, she delayed further tests.
The anchor for the modern presenting problem (abnormal bleeding with anemia). Reported from the medical historian Barron Lerner's research; no medical record was fetched.
probable Altman LK. Eva Peron and her doctors' deceit supports
Goodwin PB Jr. Perón, Eva (1919-1952). Women in World History: A Biographical Encyclopedia context
D In August 1951, much weaker, she developed increasingly severe abdominal pain and fainted again. Examination showed advanced cancer of the cervix, and Argentine doctors treated her with radium, then a standard therapy.
After the index date; recorded as history only. The modern diagnosis and treatment are synthetic.
probable Altman LK. Eva Peron and her doctors' deceit supports
Goodwin PB Jr. Perón, Eva (1919-1952). Women in World History: A Biographical Encyclopedia supports
D In October 1951 the New York cancer surgeon George Pack examined her under anesthesia to confirm the cancer, and in November 1951 he performed extensive surgery, a hysterectomy, because the cancer had spread to adjacent pelvic organs. He entered the operating room after she was anesthetized and left before she awoke. She underwent both procedures believing she had vague female problems, and was not told she had cancer; the secrecy kept the diagnosis from her and from the public during a presidential campaign.
After the index date; recorded as history only. The concealment is the teaching contrast for the modern episode, in which the diagnosis is told to her first and fully.
probable Altman LK. Eva Peron and her doctors' deceit supports
D When abdominal pain returned in February 1952, her doctors confirmed, again without telling her, that the cancer had recurred. It shrank for a time with more radiotherapy, but the pain returned in May 1952, and chemotherapy failed.
After the index date; recorded as history only.
probable Altman LK. Eva Peron and her doctors' deceit supports
D She died on July 26, 1952, at 33, never knowing that she had cervical cancer.
History only, stated without detail.
confirmed Altman LK. Eva Peron and her doctors' deceit supports
Goodwin PB Jr. Perón, Eva (1919-1952). Women in World History: A Biographical Encyclopedia supports
R A study by Nijensohn and colleagues, published online in 2011, reported evidence that she underwent a prefrontal lobotomy in Buenos Aires in the last months of her illness, for pain, anxiety and agitation from metastatic cancer; the evidence includes a neurosurgeon's memoirs and press interviews, accounts of people close to her, and skull radiographs. A later paper by the same author argued that the operation was also meant to change her behavior.
History only, without detail; a retrospective reconstruction from indirect evidence, not a medical record. Not carried into the modern episode.
possible Nijensohn DE, Savastano LE, Kaplan AD, Laws ER Jr. New evidence of prefrontal lobotomy in the last months of the illness of Eva Perón. World Neurosurg. 2012;77(3-4):583-90 (PMID 22079825) supports
Nijensohn DE. Prefrontal lobotomy on Evita was done for behavior/personality modification, not just for pain control. Neurosurg Focus. 2015;39(1):E12 (PMID 26126398) context
R The medical historian Barron Lerner, who reported the case in The Lancet in 2000, said it showed how far medical practice and ethics have changed: patients with cancer were then rarely told what they had, whereas most patients in the United States are now told their diagnosis.
An interpretation of the concealment; the reason the modern episode documents truthful, culturally sensitive disclosure to the patient herself.
probable Altman LK. Eva Peron and her doctors' deceit supports
Lerner BH. The illness and death of Eva Perón: cancer, politics, and secrecy. Lancet. 2000;355(9219):1988-91 (PMID 10859055) context
D The Pap smear, which can find cervical cancer at its earliest stage, was developed in 1942, but in 1950 it was not yet standard medical care in the United States or Argentina.
Context for the modern screening history, which is synthetic (never screened).
probable Altman LK. Eva Peron and her doctors' deceit supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Bleeding after intercourse and between periods, with heavier periods, for about four months, with tiredness and a dull pelvic ache. Never had cervical screening. Speculum examination shows a friable, exophytic mass about 4 cm across on the cervix that bleeds on contact. Punch biopsy, HPV test and cytology taken; urgent gynecologic oncology consultation booked resolved confirmed active CLM-0003
S Iron deficiency anemia from chronic blood loss: hemoglobin 9.4 g/dL, mean cell volume 72 fL, ferritin 6 ng/mL, with tiredness and breathlessness on stairs resolved confirmed active CLM-0003
S Invasive squamous cell carcinoma of the cervix, HPV 16 positive: an exophytic tumor about 4.5 cm across with clinical involvement of the left parametrium, not reaching the pelvic wall; pelvic MRI and PET-CT ordered for FIGO 2018 staging. Synthetic modern episode linked to her documented cervical cancer active confirmed active CLM-0003, CLM-0004, CLM-0005
S Acute cystitis during pelvic chemoradiation: two days of new burning, urgency and cloudy urine on top of mild radiation frequency, without fever or flank pain; urine dipstick positive for leukocyte esterase and nitrite; culture grew Escherichia coli sensitive to nitrofurantoin; neutrophil count and kidney function normal; resolved resolved confirmed active
S Ovarian failure after pelvic radiation, with hot flashes, night sweats, poor sleep and vaginal dryness two weeks after treatment; FSH 72 mIU/mL and estradiol 14 pg/mL active confirmed active CLM-0003, CLM-0004, CLM-0005

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-02-09 Hemoglobin [Mass/volume] in Blood 9.4 g/dL (low)
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-02-09 MCV [Entitic mean volume] in Red Blood Cells by Automated count 72 fL (low)
Reference 80-100 fL
http://loinc.org · 787-2
S 2026-02-09 Leukocytes [#/volume] in Blood by Automated count 7.1 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-02-09 Platelets [#/volume] in Blood by Automated count 398 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-02-09 Ferritin [Mass/volume] in Serum or Plasma 6 ng/mL (low)
Reference A ferritin of 30 ng/mL or less indicates iron deficiency
http://loinc.org · 2276-4
S 2026-02-09 Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 http://loinc.org · 72514-3
S 2026-02-09 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 2026-02-17 Creatinine [Mass/volume] in Serum or Plasma 0.7 mg/dL
Reference 0.5-1.1 mg/dL
http://loinc.org · 2160-0
S 2026-02-17 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 117 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-02-17 Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 http://loinc.org · 72514-3
S 2026-02-17 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 9 http://loinc.org · 44261-6
S 2026-02-17 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 9 http://loinc.org · 70274-6
S 2026-03-02 Hemoglobin [Mass/volume] in Blood 10.2 g/dL (low)
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-03-02 MCV [Entitic mean volume] in Red Blood Cells by Automated count 77 fL (low)
Reference 80-100 fL
http://loinc.org · 787-2
S 2026-03-02 Leukocytes [#/volume] in Blood by Automated count 6.8 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-03-02 Platelets [#/volume] in Blood by Automated count 352 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-03-02 Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 http://loinc.org · 72514-3
S 2026-03-02 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 8 http://loinc.org · 44261-6
S 2026-03-02 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 7 http://loinc.org · 70274-6
S 2026-05-18 Hemoglobin [Mass/volume] in Blood 11.2 g/dL (low)
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-05-18 Creatinine [Mass/volume] in Serum or Plasma 0.8 mg/dL
Reference 0.5-1.1 mg/dL
http://loinc.org · 2160-0
S 2026-05-18 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 101 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-05-18 Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 http://loinc.org · 72514-3
S 2026-05-18 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 http://loinc.org · 44261-6
S 2026-05-18 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 6 http://loinc.org · 70274-6
S 2026-08-17 Hemoglobin [Mass/volume] in Blood 12.6 g/dL
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-08-17 Ferritin [Mass/volume] in Serum or Plasma 48 ng/mL
Reference A ferritin of 30 ng/mL or less indicates iron deficiency
http://loinc.org · 2276-4
S 2026-08-17 Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 http://loinc.org · 72514-3
S 2026-08-17 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6
S 2026-08-17 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 4 http://loinc.org · 70274-6
S 2026-03-27 Leukocytes [#/volume] in Blood by Automated count 4.1 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-03-27 Neutrophils [#/volume] in Blood by Automated count 2.6 10*3/uL
Reference 1.5-7.5 10*3/uL
http://loinc.org · 751-8
S 2026-03-27 Hemoglobin [Mass/volume] in Blood 10.4 g/dL (low)
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-03-27 Platelets [#/volume] in Blood by Automated count 168 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-03-27 Creatinine [Mass/volume] in Serum or Plasma 0.8 mg/dL
Reference 0.5-1.1 mg/dL
http://loinc.org · 2160-0
S 2026-03-27 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 101 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-09-21 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2026-09-21 Total score [AUDIT-C] 1 http://loinc.org · 75626-2
S 2026-05-18 Follitropin [Units/volume] in Serum or Plasma 72 m[IU]/mL (high)
Reference Typical premenopausal follicular-phase range
http://loinc.org · 15067-2
S 2026-05-18 Estradiol (E2) [Mass/volume] in Serum or Plasma 14 pg/mL (low)
Reference Typical premenopausal range
http://loinc.org · 2243-4
S 2026-05-18 Magnesium [Mass/volume] in Serum or Plasma 1.9 mg/dL
Reference 1.7-2.4 mg/dL
http://loinc.org · 19123-9

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-02-09Body height165 cm8302-2S
2026-02-09Body weight53 kg29463-7S
2026-02-09Body mass index (BMI) [Ratio]19.5 kg/m239156-5S
2026-02-09Systolic blood pressure108 mm[Hg]8480-6S
2026-02-09Diastolic blood pressure68 mm[Hg]8462-4S
2026-02-09Heart rate92 /min8867-4S
2026-02-09Respiratory rate16 /min9279-1S
2026-02-09Body temperature36.8 Cel8310-5S
2026-02-09Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-02-17Body height165 cm8302-2S
2026-02-17Body weight52.8 kg29463-7S
2026-02-17Body mass index (BMI) [Ratio]19.4 kg/m239156-5S
2026-02-17Systolic blood pressure112 mm[Hg]8480-6S
2026-02-17Diastolic blood pressure70 mm[Hg]8462-4S
2026-02-17Heart rate90 /min8867-4S
2026-02-17Respiratory rate16 /min9279-1S
2026-02-17Body temperature36.7 Cel8310-5S
2026-02-17Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-03-02Body height165 cm8302-2S
2026-03-02Body weight52.5 kg29463-7S
2026-03-02Body mass index (BMI) [Ratio]19.3 kg/m239156-5S
2026-03-02Systolic blood pressure110 mm[Hg]8480-6S
2026-03-02Diastolic blood pressure68 mm[Hg]8462-4S
2026-03-02Heart rate84 /min8867-4S
2026-03-02Respiratory rate14 /min9279-1S
2026-03-02Body temperature36.7 Cel8310-5S
2026-03-02Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-05-18Body height165 cm8302-2S
2026-05-18Body weight50.6 kg29463-7S
2026-05-18Body mass index (BMI) [Ratio]18.6 kg/m239156-5S
2026-05-18Systolic blood pressure104 mm[Hg]8480-6S
2026-05-18Diastolic blood pressure66 mm[Hg]8462-4S
2026-05-18Heart rate80 /min8867-4S
2026-05-18Respiratory rate14 /min9279-1S
2026-05-18Body temperature36.6 Cel8310-5S
2026-05-18Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-08-17Body height165 cm8302-2S
2026-08-17Body weight52.4 kg29463-7S
2026-08-17Body mass index (BMI) [Ratio]19.2 kg/m239156-5S
2026-08-17Systolic blood pressure108 mm[Hg]8480-6S
2026-08-17Diastolic blood pressure68 mm[Hg]8462-4S
2026-08-17Heart rate74 /min8867-4S
2026-08-17Respiratory rate14 /min9279-1S
2026-08-17Body temperature36.6 Cel8310-5S
2026-08-17Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-03-27Body height165 cm8302-2S
2026-03-27Body weight51.4 kg29463-7S
2026-03-27Body mass index (BMI) [Ratio]18.9 kg/m239156-5S
2026-03-27Systolic blood pressure106 mm[Hg]8480-6S
2026-03-27Diastolic blood pressure66 mm[Hg]8462-4S
2026-03-27Heart rate88 /min8867-4S
2026-03-27Respiratory rate16 /min9279-1S
2026-03-27Body temperature37.2 Cel8310-5S
2026-03-27Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-09-21Body height165 cm8302-2S
2026-09-21Body weight52.8 kg29463-7S
2026-09-21Body mass index (BMI) [Ratio]19.4 kg/m239156-5S
2026-09-21Systolic blood pressure110 mm[Hg]8480-6S
2026-09-21Diastolic blood pressure70 mm[Hg]8462-4S
2026-09-21Heart rate72 /min8867-4S
2026-09-21Respiratory rate14 /min9279-1S
2026-09-21Body temperature36.6 Cel8310-5S
2026-09-21Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
Diagnosis and stage explained to her directly, in Spanish, with time for questions, before any treatment decision2026-03-02completedDiagnosis given to her in person at the second visit and the stage at the third; she made the treatment and fertility decisions herself
Hemoglobin 10 g/dL or more before radiation begins2026-03-02completedHemoglobin 10.2 g/dL
Chemoradiation and brachytherapy completed within eight weeks2026-05-18completedCompleted in eight weeks, with five cisplatin doses
No evidence of disease on PET-CT and examination three months after treatment2026-08-17completedComplete metabolic response; examination without tumor
PHQ-9 below 5 by six months2026-08-17completedPHQ-9 4

Interventions

InterventionStatusGuideline
Diagnosis of a visible cervical lesion: punch biopsy at this visit, an HPV test and cytology, a pregnancy test, a blood count and ferritin; a lesion that looks like cancer is biopsied directly rather than managed by the screening algorithmcompletedGL-ASCCP-2019, GL-NCCN-CERV-2027
Urgent gynecologic oncology consultation, on the day the biopsy result is given: diagnosis, staging, treatment by stage, and fertility and ovarian function counselingcompletedGL-NCCN-CERV-2027, GL-ASCO-FP-2018
Truthful disclosure as she asked: the biopsy result given to her in person, in Spanish, at a visit with time set aside, before anyone else is told; she chooses who is present and who is told; a professional medical interpreter for clinicians who do not speak Spanish, never a family member; information shared step by step, checking what she wants to knowcompletedGL-ASCO-COMM-2017
Iron deficiency anemia: ferrous sulfate daily, a blood count at about one month, a ferritin at the end of the course, and acetaminophen rather than anti-inflammatory painkillers for pelvic paincompletedGL-CMID-2026
FIGO 2018 staging: pelvic MRI and FDG PET-CT, kidney function before cisplatin, an HIV test, and an examination of the vagina and parametriacompletedGL-FIGO-2018, GL-NCCN-CERV-2027
Fertility and ovarian function counseling before treatment: chemoradiation ends the ability to carry a pregnancy and usually ends ovarian function; egg or embryo freezing (about two weeks), surgical moving of the ovaries out of the radiation field, and a gestational carrier were explained; her decision is recordedcompletedGL-ASCO-FP-2018, GL-NCCN-CERV-2027
Psychosocial support: the oncology social worker, the PHQ-9 and GAD-7 at diagnosis, before treatment, at the end of treatment and in follow-up, spiritual care when she asks, and help planning work around treatmentcompletedGL-ASCO-ANXDEP-2023, GL-ASCO-COMM-2017
Definitive chemoradiation for stage IIB disease: pelvic external beam radiation 45 Gy in 25 fractions with weekly cisplatin 40 mg/m2, then image-guided high-dose-rate brachytherapy, all within eight weeks; weekly blood count, creatinine and magnesium; ondansetron for nausea and loperamide for diarrheacompletedGL-NCCN-CERV-2027, GL-FIGO-2018
Survivorship care: a vaginal dilator three times a week, estradiol with progesterone for radiation-induced menopause until the usual age of menopause, gynecologic oncology review every three months for two years, PET-CT about three months after treatment, and warning symptoms to reportcompletedGL-NCCN-CERV-2027

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Altman LK. Eva Peron and her doctors' deceit Tampa Bay Times (St. Petersburg Times) other
SRC-0002 Goodwin PB Jr. Perón, Eva (1919-1952). Women in World History: A Biographical Encyclopedia Gale, via Encyclopedia.com biography
SRC-0003 Lerner BH. The illness and death of Eva Perón: cancer, politics, and secrecy. Lancet. 2000;355(9219):1988-91 (PMID 10859055) The Lancet scholarly
SRC-0004 Nijensohn DE, Savastano LE, Kaplan AD, Laws ER Jr. New evidence of prefrontal lobotomy in the last months of the illness of Eva Perón. World Neurosurg. 2012;77(3-4):583-90 (PMID 22079825) World Neurosurgery scholarly
SRC-0005 Nijensohn DE. Prefrontal lobotomy on Evita was done for behavior/personality modification, not just for pain control. Neurosurg Focus. 2015;39(1):E12 (PMID 26126398) Neurosurgical Focus scholarly
SRC-0006 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check direct biopsy of a visible lesion, FIGO 2018 stage IIB by MRI and PET-CT, chemoradiation with weekly cisplatin and brachytherapy within eight weeks, the fertility counseling and her decision, estradiol with progesterone for radiation-induced menopause with the uterus in place, and the documentation of disclosure.
provenance reviewnot_startedLawrence K. Altman's newspaper report of Barron Lerner's Lancet article (Tampa Bay Times, 2000), the Gale Women in World History entry, and two PubMed abstracts by Nijensohn logged; Lerner's Lancet article itself is cited without its text. The illness claims are D with certainty probable because they rest on Lerner's research as reported; the lobotomy is R, possible.
safe messaging reviewnot_startedThe reported lobotomy is recorded once, as history only, marked sensitive, without detail, and is not carried into the modern episode. Political material is limited to what identifies her and explains the secrecy. No modern role is given to any real person.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.